In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
One column page  
  • Heart Failure 2015

    Take part in the exchange and join the world's leading heart failure communities in Seville.

  • EACVI Echocardiography e-learning course

    Discover the first module of the complete Echo e-learning course.

    An extensive programme providing practical training on how to perform echo exams, covering the EACVI Echo Core Syllabus.

  • ESC webinars on demand

    Play back for free the recordings of all the previous live ESC webinars on general cardiology.

  • Paroxysmal tachycardias: Catheter ablation of supraventricular tachycardias - the non-electrophysiologist’s perspective – Second in series

    Authors: Stylianos Tzeis

    Over the past decades, catheter ablation has increasingly been recognised as an effective method for the treatment of diverse types of cardiac arrhythmias. Introduction, development and our growing experience with three dimensional mapping systems have improved both the safety and efficacy of this invasive therapy. In the following...

  • EuroEcho-Imaging 2015

    Submit an abstract and be part of EuroEcho-Imaging 2015, the annual meeting of the European Association of Cardiovascular Imaging (EACVI) in Seville from 2 to 5 December 2015. This year's main themes are Cardiomyopathies and Early diagnosis of cardiovascular diseases.
    Prepare your original scientific contribution and submit your abstract before 31 May.

  • ESC Congress 2015

    Take part in the world's largest and most influential cardiovascular event.
    Register before 31 May and benefit from the early fee registration rate.

Latest News

  • Cognitive impairment predicts worse outcome in heart failure

    May 24, 2015


    Cognitive impairment predicts worse outcome in elderly heart failure patients, reveals research presented today at Heart Failure 2015 by Hiroshi Saito, a physiotherapist at Kameda Medical Centre in Kamogawa, Japan. Patients with cognitive impairment had a 7.5 times greater risk of call cause death and heart failure readmission.

  • Obesity and mood disorders increase peripartum cardiomyopathy risk

    May 23, 2015

    Obesity and mood disorders increase the risk of peripartum cardiomyopathy (PPCM) during childbirth, reveals research presented today at Heart Failure 2015 by Dr David P. Kao, assistant professor at the University of Colorado in Denver, US.

  • Depression associated with 5-fold increased mortality risk in heart failure patients

    May 23, 2015

    Moderate to severe depression is associated with a 5-fold increased risk of all cause mortality in patients with heart failure, according to research presented today at Heart Failure 2015.

  • TITRATION study confirms LCZ696 safe and tolerated in clinical practice

    May 23, 2015

    The TITRATION study has confirmed that LCZ696 is safe and tolerated by patients with heart failure and reduced ejection fraction (HFrEF) in clinical practice, announced principal investigator Dr Michele Senni in a late breaking trials session today at Heart Failure 2015

  • Cardiovascular nurses discuss the latest in evidence based care

    May 22, 2015

    The cardiovascular nursing event of the year is heading south to Croatia. EuroHeartCare is the official annual meeting of the Council on Cardiovascular Nursing and Allied Professions (CCNAP) of the European Society of Cardiology (ESC).

  • Time is muscle in acute heart failure

    May 22, 2015

    Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

  • Therapeutic innovations to be revealed at arrhythmias conference

    May 21, 2015

    Innovations in arrhythmias therapy are set to be revealed at EHRA EUROPACE – CARDIOSTIM 2015, held 21 to 24 June in Milan, Italy at the MiCo Milano Congressi.

  • Low stent thrombosis rates with primary PCI, regardless of antithrombotic choice

    May 21, 2015

    Stent thrombosis following urgent angioplasty for acute heart attack occurred in less than 1% of patients in a large, "real-world" registry, regardless of whether the antithrombotic treatment used during the procedure was bivalirudin, heparin alone, or a GP IIb/IIIa inhibitor (typically in combination with heparin).

  • Dr. Shigeru Saito and Dr. Ferdinand Kiemeneij receive Ethica Award

    May 20, 2015

    EuroPCR, the annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) and the world-leading course in interventional medicine, honoured Dr. Ferdinand Kiemeneij from the Netherlands and Dr. Shigeru Saito from Japan as this year's recipients of the 2015 Ethica Award. The award acknowledges their roles in pioneering and teaching the radial approach for coronary catheterization.

  • Advances in mechanical thrombectomy warrant call to action in acute stroke

    May 20, 2015

    Experts speaking at EuroPCR 2015 say the explosion of positive results for new-generation endovascular devices for the treatment of acute stroke warrant a call to action to ensure swifter implementation of this technology. Known as "stent-retrievers," mechanical thrombectomy devices use catheters introduced into a blocked cerebral artery to suck out or lyse a clot that is cutting off circulation to part of the brain.

  • European society of cardiology

     

    The European Society of Cardiology (ESC) represents over 85 000 cardiology professionals from Europe, the Mediterranean basin and the rest of the world. Based at the European Heart House, Sophia-Antipolis (France), the ESC publishes guidelines and recommendations for clinical practice, runs major conferences and educational programmes and supports scientific endeavours across Europe and in all areas of cardiology. Read more

    With the European Heart Agency in Brussels, the ESC supports the development of strong policies for the prevention of cardiovascular disease in the European Union. The European Heart Agency comprises three branches: European Affairs, the European Heart Health Institute, and the European Heart Academy. Read more

Calendar

Find out more about the ESC Congress and other sub-specialty cardiology meetings

We organise leading scientific courses and congresses: The ESC Congress, the largest medical meeting in Europe, aims to be the European forum for the latest research in cardiovascular disease, both clinical and experimental. Other Congresses organised by the ESC include EuroEcho-Imaging, EHRA Europace, Heart Failure, EuroPRevent, ICNC and many others...

23

May

14

Jun

21

Jun

29

Aug

17

Oct

02

Dec

12

May

European Heart Journal

Direct access to the journal Table of Contents. The European Heart Journal is the official general cardiology journal of the ESC. The European Heart Journal aims to publish the highest quality material, both clinical and scientific, on all aspects of cardiovascular medicine.
Date published Title
21 May 2015 Interventional cardiology: in search of the balance between ischaemia and bleeding
Topic(s):ISSUE @ A GLANCE
Author(s): Luscher, T. F.
21 May 2015 CardioPulse Articles * New perspectives: transcatheter aortic valve implantation in the year 2020 * The evolution of MitraClip in the repair of mitral regurgitation * Relationship between hospital PTCA volume and in-hospital outcomes * The ninth international conference on acute cardiac care in Tel Aviv, January 2015 * European Heart Journal Supplement - the heart of the matter * People's Corner: Award * The new research prize for arrhythmogenic right ventricular cardiomyopathy/dysplasia awarded to Vincent Chen
Topic(s):CardioPulse
Author(s):
21 May 2015 Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?
Topic(s):Editor's Viewpoint
Author(s): Binder, R. K., Luscher, T. F.
21 May 2015 Prognosis after revascularization for left main coronary artery disease: insights from the crystal ball
Topic(s):Editor's Viewpoint
Author(s): Byrne, R. A., Kastrati, A.
21 May 2015 Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy
Topic(s):Editor's Viewpoint
Author(s): Yeh, R. W., Cohen, D. J., Mauri, L.
21 May 2015 Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?
Topic(s):Editor's Viewpoint
Author(s): Valgimigli, M., Ariotti, S., Costa, F.
21 May 2015 Management of cardiogenic shock
Topic(s):Clinical update
Author(s): Thiele, H., Ohman, E. M., Desch, S., Eitel, I., de Waha, S.
21 May 2015 Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II
Topic(s):Coronary artery disease
Author(s): Campos, C. M., van Klaveren, D., Farooq, V., Simonton, C. A., Kappetein, A.-P., Sabik, J. F., Steyerberg, E. W., Stone, G. W., Serruys, P. W., On Behalf of the EXCEL Trial Investigators
21 May 2015 A rare cause of cardiogenic shock
Topic(s):CARDIOVASCULAR FLASHLIGHTS
Author(s): den Uil, C. A., Epker, J. L.
21 May 2015 Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial
Topic(s):Interventional cardiology
Author(s): Costa, F., Vranckx, P., Leonardi, S., Moscarella, E., Ando, G., Calabro, P., Oreto, G., Zijlstra, F., Valgimigli, M.
21 May 2015 ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
Topic(s):Thrombosis and antithrombotic therapy
Author(s): Schulz-Schupke, S., Byrne, R. A., ten Berg, J. M., Neumann, F.-J., Han, Y., Adriaenssens, T., Tolg, R., Seyfarth, M., Maeng, M., Zrenner, B., Jacobshagen, C., Mudra, H., von Hodenberg, E., Wohrle, J., Angiolillo, D. J., von Merzljak, B., Rifatov, N., Kufner, S., Morath, T., Feuchtenberger, A., Ibrahim, T., Janssen, P. W. A., Valina, C., Li, Y., Desmet, W., Abdel-Wahab, M., Tiroch, K., Hengstenberg, C., Bernlochner, I., Fischer, M., Schunkert, H., Laugwitz, K.-L., Schomig, A., Mehilli, J., Kastrati, A., On behalf of the Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Trial Investigators
21 May 2015 Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial
Topic(s):Thrombosis and antithrombotic therapy
Author(s): Held, C., Hylek, E. M., Alexander, J. H., Hanna, M., Lopes, R. D., Wojdyla, D. M., Thomas, L., Al-Khalidi, H., Alings, M., Xavier, D., Ansell, J., Goto, S., Ruzyllo, W., Rosenqvist, M., Verheugt, F. W. A., Zhu, J., Granger, C. B., Wallentin, L.
21 May 2015 Very late thrombosis observed on optical coherence tomography 22 months after the implantation of a polymer-based bioresorbable vascular scaffold
Topic(s):CARDIOVASCULAR FLASHLIGHTS
Author(s): Sato, T., Abdel-Wahab, M., Richardt, G.

HighlightS

ESC Congress 365

Your free access to ESC Congress content all year long 

View thousands of webcasts, slides, abstracts and reports from the world's leading cardiology congress – online, anytime, without subscription!

Access now
The ESC eLearning platform

The ESC eLearning platform is a web based tool which facilitates the harmonisation of cardiovascular training in cardiology.
Discover the platform in your area of study!

Read more
E-Journal of Cardiology Practice

You know about the challenges of keeping up to date with the latest research results or best practices. The E-journal is a weekly e-mail written by leading experts in Europe, summarising an important topic in cardiology.

Subscribe to receive the E-journal of Cardiology Practice

Read more

Our Communities

The European Society of Cardiology comprises 6 Associations, 15 Working Groups, 5 Councils

Acute Cardiovascular Care Association
Acute Cardiovascular Care Association (ACCA)

Our mission: To improve the quality of care and outcomes of patients with acute cardiovascular diseases.

European Association for Cardiovascular Prevention & Rehabilitation
European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

 Our mission: To promote excellence in research, practice, education and policy in cardiovascular prevention and rehabilitation in Europe.

European Association of Cardiovascular Imaging (EACVI)
European Association of Cardiovascular Imaging (EACVI)

Our mission: To promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.

European Association of Percutaneous Cardiovascular Interventions (EAPCI)
European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Our mission: To reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.

European Heart Rhythm Association
European Heart Rhythm Association (EHRA)
 Our mission: To improve the quality of life of the European population by reducing the impact of cardiac arrhythmias and reduce sudden cardiac death.
Heart Failure Association (HFA) of the ESC
Heart Failure Association of the ESC (HFA)

Our mission: To improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.


 

 

Back to top

Who we are

What we do

How we work

More ESC